综述:拓展肠道超声知识、性能与应用的前沿
主要空白包括缺乏验证的标准化活动指数、术后复发、儿科及肛周/储袋疾病证据有限,超声造影和弹性成像数据稀疏,培训与人工智能应用探索不足。
要点
- IBD肠道超声证据存在显著空白,缺乏验证的标准化活动指数。
- 术后复发、儿科及肛周/储袋疾病中肠道超声证据有限。
- 超声造影和弹性成像数据稀疏,培训与AI整合未充分探索。
核心结论
- IBD肠道超声证据基础存在显著空白,需通过稳健的多中心研究和共识框架优化其临床与研究效用。
主要发现
- 缺乏验证和标准化的克罗恩病与溃疡性结肠炎肠道超声活动指数。
- 术后复发、儿科人群及肛周或储袋疾病中肠道超声证据有限。
- 超声造影和弹性成像数据稀疏。
- 多数研究受样本量小、设计异质性和随访不足限制。
- 培训、能力评估和人工智能整合仍未充分探索。
临床怎么用
- 临床应认识到肠道超声在IBD中的应用证据尚不充分,尤其在术后复发、儿科和肛周/储袋疾病中需谨慎解读。
局限性
- 纳入研究多存在样本量小、设计异质性和随访不足的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intestinal ultrasonography (IUS) is increasingly utilised for diagnosing and monitoring IBD. Despite its cost-effectiveness, patient tolerance and suitability for serial bedside assessments, broad adoption has been limited by knowledge gaps in evidence, training and standardisation. AIMS: To summarise key knowledge gaps in the assessment of luminal disease activity, postoperative recurrence, complications, pouch-related disorders and the use of IUS in paediatrics, contrast enhancement, elastography, as well as education, training and future applications involving artificial intelligence. METHODS: We conducted a systematic umbrella review, following PRISMA guidelines, to map the current landscape of high-quality evidence and identify gaps in IUS research relevant to IBD. We searched MEDLINE from inception to February 2025 for systematic reviews, meta-analyses and consensus statements. We extracted data from eligible studies on design, outcomes and identified research gaps. Gaps were categorised by insufficient information, bias, inconsistency or lack of relevant data. RESULTS: Sixty of 507 studies met inclusion criteria. Key gaps included lack of validated and standardised IUS activity indices for Crohn's disease and ulcerative colitis, limited evidence for IUS in post-operative recurrence, paediatric populations and perianal or pouch disease. Data on the use of contrast-enhanced ultrasound and elastography were sparse. Small sample sizes, heterogeneous designs and inadequate follow-up limited most studies. Training, competency assessment and integration of artificial intelligence remain underexplored. CONCLUSIONS: Sizable gaps persist in the evidence base for IUS in IBD. Addressing these gaps through robust, multicentre studies and consensus-driven frameworks is essential to optimise the clinical and research utility of IUS in IBD management.
引用
- Lu C, Verstockt B, Winter MW, et al. Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion. Aliment Pharmacol Ther. 2025. PMID: 41235810. doi:10.1111/apt.70449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。